Search Results
199 items found for "Network pharmacology"
- GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma
Through genetic and pharmacologic modulations of GRK3, a series of functional and molecular studies were
- G protein-coupled receptor signaling: transducers and effectors
We will first summarize their prominent roles in GPCR pharmacology before transitioning into less well-explored
- 📰 GPCR Weekly News, May 15 to 21, 2023
(June 4 - 8, 2023). 2023 Molecular Pharmacology (GRS) Seminar GRC. (June 10 - 11, 2023). Adrenoceptors and GPCR Signalling (June 30 - July 1, 2023) 19th World Congress of Basic & Clinical Pharmacology
- Opioid Ligands Addressing Unconventional Binding Sites and More Than One Opioid Receptor Subtype
develop drugs with less side effects, and tools to explore the ORs nature and function, various (poly)pharmacological
- 📰 Breaking Down the Latest GPCR Discoveries: a Weekly Update (Nov 27-Dec 3, 2023)
new method for studying GPCR expression GPCR molecular dynamics forecasting using recurrent neural networks Chemotactic Cytokines NEW June 9 - 14, 2024 | 2024 Phosphorylation and G-Protein Mediated Signaling Networks , 2024 | 11th Adhesion GPCR Workshop July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology
- Michel Bouvier appointed Knight of the Ordre national du Québec
22, 2022, Michel Bouvier, Chief Executive Officer of IRIC, Principal Investigator of the Molecular Pharmacology
- Developing the Cannabinoid Receptor 2 (CB2) pharmacopoeia: past, present, and future
development and progress in optimising physicochemical properties, understanding advanced molecular pharmacology
- Targeting Intracellular Allosteric Sites in GPCRs
Recent advances in structural biology and pharmacology have revealed the existence of allosteric sites Allosteric modulators targeting GPCRs can display one or more of the following pharmacological characteristics their allosteric influence, an attribute that offers a considerable degree of adjustability in terms of pharmacological
- Developing the Cannabinoid Receptor 2 (CB2) pharmacopeia: past, present, and future
development and progress in optimizing physicochemical properties, understanding advanced molecular pharmacology
- G protein-coupled receptor 21 in macrophages: An in vitro study
analyzing (i) its involvement in cell migration and cytokine release and (ii) the consequence of its pharmacological
- Molecular basis for ligand modulation of the cannabinoid CB 1 receptor
LINKED ARTICLES: This article is part of a themed issue on Structure Guided Pharmacology of Membrane
- Therapeutic validation of an orphan G protein-coupled receptor: The case of GPR84
of GPR84 and, in the absence of direct structural information, recent developments and use of GPR84 pharmacological
- Interacting binding insights and conformational consequences of the differential activity of...
major non-psychoactive phytocannabinoid present in the plant Cannabis sativa, has displayed beneficial pharmacological Our work will pave the way for understanding the CBD pharmacology at a molecular level and aid in harnessing
- 📰 GPCR Weekly News, June 19 to 25, 2023
Adrenoceptors and GPCR Signalling (June 30 - July 1, 2023) 19th World Congress of Basic & Clinical Pharmacology GPCRs, Ion Channels, and Transport Proteins (March 24 - 29, 2024) GPCR Jobs Professor in Cardiovascular Pharmacology
- Label-free LC-MS based assay to characterize small molecule compound binding to cells
small molecule binding to live cells provides important information on the characterization of ligands pharmacologically
- Nanobodies as Probes and Modulators of Cardiovascular G Protein-Coupled Receptors
Here, we review how nanobodies have been adopted to elucidate the structure, pharmacology, and signaling
- Fluorescent Ligands Targeting Intracellular Allosteric Binding Site of the Chemokine Receptor CCR2
small-molecule-based fluorescent CCR2 ligand 14 represents a promising tool for future studies of CCR2 pharmacology
- Biased Agonism at the GLP-1 Receptor: A Pathway to Improved Therapeutic Outcomes
underlying biased agonism at the GLP-1R are beginning to be elucidated through a combination of mutagenesis, pharmacological Biochemical Pharmacology, 2024. 222 : p. 116119. 5.
- From DNA day to GPCR genomics
The integration of genomics with structural biology, pharmacology, bioinformatics, and clinical research Molecular pharmacology, 63(6), 1256–1272. https://doi.org/10.1124/mol.63.6.1256 Syed Haneef, S.
- 📰 GPCR Weekly News, November 6 to November 12, 2023
9th GPCRs in Medicinal Chemistry NEW July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology Antibody Discovery Staff Scientist (AC-TAP) in Database Development at Department of Drug Design and Pharmacology
- 📰 GPCR Weekly News, June 5 to 11, 2023
Berchiche is at the Molecular Pharmacology GRC, if you are also on-site, please stop by and say hi. Adrenoceptors and GPCR Signalling (June 30 - July 1, 2023) 19th World Congress of Basic & Clinical Pharmacology
- Dr. Kevin Pfleger and Dr. Elizabeth Johnstone were awarded one of the 2022 Diabetes Research...
This $60,000 grant from Diabetes Research WA will assist the Perkins' Molecular Endocrinology and Pharmacology
- A broad look into the future of systemic sclerosis
Pharmacological interventions, although for other indications, are already in clinical use to address
- Pepducin-mediated G Protein-Coupled Receptor Signaling in the Cardiovascular System
Over the past 2 decades, pepducins have progressed initially from pharmacologic tools used to manipulate
- Coincident Regulation of PLCβ Signaling by Gq-Coupled and μOpioid Receptors Opposes Opioid- Mediated
Knockout of PLCβ3, or pharmacological inhibition of its upstream regulators, Gβγ or Gq, ex vivo in periaqueductal
- Rhodopsin as a Molecular Target to Mitigate Retinitis Pigmentosa
chaperones to improve the folding and stability of the mutant receptor is one of the most promising pharmacological
- 📰 GPCR Weekly News, August 28 to September 3, 2023
female common diseases: a guard of women's health β-Arrestins: Structure, Function, Physiology, and Pharmacological Postdoc Research Associate Director, Regulatory Affairs Research Scientist/Senior Scientist I - Molecular Pharmacology
- Glyco-sulfo hotspots in the chemokine receptor system
O-glycosylation in their N-termini as well as sulfation, both PTMs which co-localize in the Trans-Golgi network effects of O-glycosylation and tyrosine sulfation modulation on the chemokine receptors CCR1 and CCR5 pharmacology evidence proposes that O-glycosylation and sulfation are important PTMs in chemokine receptor biology and pharmacology